Korro Bio, Inc. (NASDAQ:KRRO – Get Free Report) major shareholder Venture Opportunity Fund Atlas bought 17,857 shares of Korro Bio stock in a transaction dated Monday, April 22nd. The stock was purchased at an average cost of $56.00 per share, with a total value of $999,992.00. Following the completion of the acquisition, the insider now […]